News | April 30, 2008

Breast Surgeons Benefit from Ultrasound-Guidance Portfolio

May 1, 2008 - Hologic Inc. said yesterday at the American Society of Breast Surgeons conference in New York City that U.S. breast surgeons are among the first to realize the benefits of Hologic product integrations stemming from recent company mergers, acquisitions and partnerships.
The Suros Celero spring-loaded, vacuum assisted core biopsy device, SecurMark for Celero biopsy site identifier, MammoSite five-day radiation therapy system and a recent agreement with Mindray Medical International to sell the to DP-6600 digital ultrasonic diagnostic imaging system, allows Hologic to offer a comprehensive ultrasound-guided portfolio to the U.S. breast surgery market.

“With Hologic offering a full line of ultrasound breast care products, we are able to drastically shorten the time it takes from performing an abnormal ultrasound biopsy to giving the patient a diagnosis,” said Thomas Heck, M.D., FACS, medical director of the Samaritan Breast Center in Dayton, Ohio. “The waiting period is sometimes now just one day. This is a huge help in significantly lowering patient anxiety.”

SecurMark biopsy site identifiers are one of Hologic’s newest product releases. SecurMark identifiers use a biocompatible titanium clip surrounded by a bio-absorbable suture-like material designed to minimize marker movement within the biopsy cavity and help visualize the marker under traditionally challenging circumstances in the ultrasound environment. SecurMark site identifiers preliminarily indicates visibility 2-3 weeks after deployment, reportedly making it effective for surgeons in accurately guiding them with wire localization should a follow up lumpectomy be necessary. After four months, the Glycoprene netting surrounding the marker shows no visual evidence and is safely and fully absorbed into the body. SecurMark for Celero site identifiers are available in two shapes to provide differentiating images and the ability to diagnose breast disease independently for multiple biopsy sites in a single breast.

“I like the fact that with the Celero, you can pre-fire directly to the lesion and you know you won’t fire past it,” said Dr. Heck. “It provides me with excellent specimens that our pathologists are very happy with and bleeding has not been an issue. Patient care is enhanced because we can make a definitive diagnosis much quicker. It’s the right thing to do and the way a breast center should operate.”

Quehuong Pham, M.D., general surgeon at Inverness Surgical Associates in Inverness, FL notes that the DP-6600 digital ultrasonic diagnostic imaging system gives breast surgeons the ability to provide comprehensive patient care in their office, without the need to refer patients to radiologists for imaging and possible wire localization for a later surgical procedure.

“I see a significant benefit to what Hologic is offering as an ultrasound package,” Dr. Pham said. “Having the ability to image the breast, easily perform a biopsy and mark the biopsy site, and then also provide disease treatment with the MammoSite radiation therapy system, if necessary, really makes my practice very efficient and offers my patients convenience. Not only does this benefit me with scheduling, but also in planning my surgical cases.”

For more information: www.hologic.com

Related Content

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.
Automated Triage of Thyroid Cancer

73-year-old man with papillary carcinoma of left lobe of thyroid. Screen shot shows example of thyroid nodule annotation (segmentation and TI-RADS annotation) performed on ultrasound image in longitudinal projection with electronic Physician Annotation Device software (Stanford Medicine Radiology). Radiologists performed nodule segmentation by selecting points (red) on nodule outline (green), while controlling smoothing of outline polygon by means of spline interpolation.

News | Ultrasound Imaging | January 30, 2020
January 30, 2020 — According to an ar...
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Sponsored Content | Videos | Ultrasound Imaging | January 06, 2020
The Arietta 850SE provides facilities with numerous features and functionality to get the most out of a system.
Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Feature | Radiation Oncology | January 03, 2020 | Dave Fornell, Editor
January 3, 2020 — Here is the top 20 pieces of radiation oncology content on the Imaging Technology News (ITN) websit